Published in Neurology on December 26, 2006
Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis. Neurology (2013) 1.40
Optical coherence tomography in parkinsonian syndromes. PLoS One (2012) 1.24
Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis. Neuroimage Clin (2013) 1.23
Regional brain stem atrophy in idiopathic Parkinson's disease detected by anatomical MRI. PLoS One (2009) 1.12
Clinical correlates of white matter tract degeneration in progressive supranuclear palsy. Arch Neurol (2011) 1.05
Utility of susceptibility-weighted MRI in differentiating Parkinson's disease and atypical parkinsonism. Neuroradiology (2010) 1.03
Automated, high accuracy classification of Parkinsonian disorders: a pattern recognition approach. PLoS One (2013) 0.95
Diffusion tensor tractography of the human brain cortico-ponto-cerebellar pathways: a quantitative preliminary study. J Magn Reson Imaging (2010) 0.94
Diffusion tensor imaging of the cortico-ponto-cerebellar pathway in patients with adult-onset ataxic neurodegenerative disease. Neuroradiology (2008) 0.93
Fiber tracking functionally distinct components of the internal capsule. Neuropsychologia (2010) 0.92
Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis. Mov Disord (2010) 0.88
A review of the use of magnetic resonance imaging in Parkinson's disease. Ther Adv Neurol Disord (2014) 0.88
Diffusion tensor imaging of Parkinson's disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics study. PLoS One (2014) 0.88
Brainstem involvement as a cause of central sleep apnea: pattern of microstructural cerebral damage in patients with cerebral microangiopathy. PLoS One (2013) 0.87
PROBABILISTIC PREDICTION OF NEUROLOGICAL DISORDERS WITH A STATISTICAL ASSESSMENT OF NEUROIMAGING DATA MODALITIES. Ann Appl Stat (2012) 0.86
Magnetic resonance imaging in progressive supranuclear palsy. J Neurol (2010) 0.83
A decision tree for differentiating multiple system atrophy from Parkinson's disease using 3-T MR imaging. Eur Radiol (2013) 0.83
Diffusion tensor imaging parameters' changes of cerebellar hemispheres in Parkinson's disease. Neuroradiology (2014) 0.82
Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonism. Neuroradiology (2015) 0.81
Cortical thickness, surface area and volume measures in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. PLoS One (2014) 0.81
Examining the relationship between head trauma and neurodegenerative disease: A review of epidemiology, pathology and neuroimaging techniques. J Alzheimers Dis Parkinsonism (2014) 0.80
Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy. Neuroradiology (2015) 0.79
White and gray matter abnormalities in narcolepsy with cataplexy. Sleep (2012) 0.79
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be? Mov Disord (2017) 0.77
Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders? Mol Neurobiol (2015) 0.76
Voxelwise meta-analysis of white matter abnormalities in progressive supranuclear palsy. Neurol Sci (2013) 0.76
Primary lateral sclerosis as progressive supranuclear palsy: diagnosis by diffusion tensor imaging. Mov Disord (2012) 0.75
Combined Diffusion Tensor Imaging and Apparent Transverse Relaxation Rate Differentiate Parkinson Disease and Atypical Parkinsonism. AJNR Am J Neuroradiol (2017) 0.75
Brain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An Update. Parkinsons Dis (2016) 0.75
Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts. Transl Neurodegener (2017) 0.75
Diffusion tensor imaging of the human cerebellar pathways and their interplay with cerebral macrostructure. Front Neuroanat (2015) 0.75
Parkinsonian syndromes. Neurol Sci (2008) 0.75
An investigation of diffusion imaging techniques in the evaluation of spinocerebellar ataxia and multisystem atrophy. J Clin Neurosci (2014) 0.75
Diffusion tensor imaging in Parkinson's disease: Review and meta-analysis. Neuroimage Clin (2017) 0.75
Magnetic resonance imaging for the diagnosis of Parkinson's disease. J Neural Transm (Vienna) (2017) 0.75
A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science (1995) 15.20
Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci (2003) 10.44
Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn Reson Med (1999) 8.94
Estimating the burden of musculoskeletal disorders in the community: the comparative prevalence of symptoms at different anatomical sites, and the relation to social deprivation. Ann Rheum Dis (1998) 5.76
Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet (1996) 4.11
Social intelligence in the normal and autistic brain: an fMRI study. Eur J Neurosci (1999) 3.94
Phytochrome regulation and differential expression of gibberellin 3beta-hydroxylase genes in germinating Arabidopsis seeds. Plant Cell (1998) 3.76
Detection and modeling of non-Gaussian apparent diffusion coefficient profiles in human brain data. Magn Reson Med (2002) 3.53
Mapping motor inhibition: conjunctive brain activations across different versions of go/no-go and stop tasks. Neuroimage (2001) 3.51
Evidence for cortical "disconnection" as a mechanism of age-related cognitive decline. Neurology (2001) 3.30
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet (1992) 3.30
Non-invasive assessment of axonal fiber connectivity in the human brain via diffusion tensor MRI. Magn Reson Med (1999) 3.22
The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res (2004) 2.72
Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI. Am J Psychiatry (1999) 2.72
Technique for measuring hippocampal T2 relaxation time. AJNR Am J Neuroradiol (1997) 2.65
Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain (1992) 2.64
The anatomy of melancholia--focal abnormalities of cerebral blood flow in major depression. Psychol Med (1992) 2.58
Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry (2001) 2.55
Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med (1990) 2.55
Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology (1999) 2.54
Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain (1996) 2.54
Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. J Virol (1984) 2.48
An interpretation of the modern rise of population in Europe. Popul Stud (Camb) (1972) 2.45
Diffusion tensor imaging can detect and quantify corticospinal tract degeneration after stroke. J Neurol Neurosurg Psychiatry (2000) 2.44
'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain (1988) 2.36
Functional frontalisation with age: mapping neurodevelopmental trajectories with fMRI. Neurosci Biobehav Rev (2000) 2.31
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis (2004) 2.29
Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (1998) 2.28
An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry (2010) 2.14
Remission of inflammatory arthropathy in association with anti-CD20 therapy for non-Hodgkin's lymphoma. Rheumatology (Oxford) (1999) 2.14
Test liquids for quantitative MRI measurements of self-diffusion coefficient in vivo. Magn Reson Med (2000) 2.14
Hospitalist concept: another dangerous trend. Am Fam Physician (1998) 2.11
Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology (2002) 2.09
Functional magnetic resonance imaging of synesthesia: activation of V4/V8 by spoken words. Nat Neurosci (2002) 2.05
Proteome-based plasma biomarkers for Alzheimer's disease. Brain (2006) 1.98
Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology (1999) 1.98
How common is dementia in Parkinson's disease? Lancet (1984) 1.93
Specific absorption of human serum albumin, immunoglobulin A, and immunoglobulin G with selected strains of group A and G streptococci. Infect Immun (1979) 1.92
A structural equation modeling investigation of age-related variance in executive function and DTI measured white matter damage. Neurobiol Aging (2007) 1.92
EEG-triggered functional MRI of interictal epileptiform activity in patients with partial seizures. Brain (1999) 1.88
Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett (1992) 1.82
Apathy in Parkinson's disease. J Neurol Neurosurg Psychiatry (2002) 1.82
Neuropathological abnormalities of the corpus callosum in schizophrenia: a diffusion tensor imaging study. J Neurol Neurosurg Psychiatry (2000) 1.81
Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia (2000) 1.80
Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2002) 1.80
Precise estimate of fundamental in-vivo MT parameters in human brain in clinically feasible times. Magn Reson Imaging (2002) 1.80
Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol (1998) 1.80
Generic brain activation mapping in functional magnetic resonance imaging: a nonparametric approach. Magn Reson Imaging (1997) 1.78
A multicenter measurement of magnetization transfer ratio in normal white matter. J Magn Reson Imaging (1999) 1.76
New VAPB deletion variant and exclusion of VAPB mutations in familial ALS. Neurology (2008) 1.76
MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology (2001) 1.75
Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features. J Neurol Neurosurg Psychiatry (1996) 1.74
The impact of deep brain stimulation on executive function in Parkinson's disease. Brain (2000) 1.74
Identification of novel herpes simplex virus replicative intermediates by field inversion gel electrophoresis: implications for viral DNA amplification strategies. Virology (1994) 1.73
Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry (2004) 1.72
Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology (2009) 1.71
Dopaminergic drug effects on physiological connectivity in a human cortico-striato-thalamic system. Brain (2003) 1.70
Normal-appearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study. Neurology (2001) 1.69
Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain (1994) 1.68
Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS. Neurology (2001) 1.68
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2013) 1.65
Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol Med (1993) 1.65
Towards a functional neuroanatomy of self processing: effects of faces and words. Brain Res Cogn Brain Res (2000) 1.62
Respiratory aspects of neurological disease. J Neurol Neurosurg Psychiatry (1999) 1.61
Voxel similarity measures for 3-D serial MR brain image registration. IEEE Trans Med Imaging (2000) 1.61
Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale. Eur J Neurol (2013) 1.61
Diffusion tensor imaging in patients with epilepsy and malformations of cortical development. Brain (2001) 1.60
Cognitive behavioural therapy (CBT) for carers of patients with Parkinson's disease: a preliminary randomised controlled trial. J Neurol Neurosurg Psychiatry (2005) 1.59
Erythropoietin depletion and anaemia in diabetes mellitus. Diabet Med (1999) 1.59
High field MRI correlates of myelin content and axonal density in multiple sclerosis--a post-mortem study of the spinal cord. J Neurol (2003) 1.59
Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry (1996) 1.58
Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology (2001) 1.58
What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study. Neurology (1997) 1.58
Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry (1999) 1.57
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS. Neurology (2007) 1.56
Differential corticospinal tract degeneration in homozygous 'D90A' SOD-1 ALS and sporadic ALS. J Neurol Neurosurg Psychiatry (2011) 1.55
Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet (1999) 1.54
Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup? J Neurol Neurosurg Psychiatry (1999) 1.53
Serial magnetization transfer imaging to characterize the early evolution of new MS lesions. Neurology (1998) 1.53
Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain (1995) 1.53
Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). Neuroepidemiology (2007) 1.52
Physiological assessment of aspects of autonomic function in patients with secondary progressive multiple sclerosis. J Neurol (1993) 1.52
Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2003) 1.52
Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs. J Intern Med (2013) 1.52
Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol (2001) 1.52
Accurate multislice gradient echo T(1) measurement in the presence of non-ideal RF pulse shape and RF field nonuniformity. Magn Reson Med (2001) 1.51
Diffusion tractography based group mapping of major white-matter pathways in the human brain. Neuroimage (2003) 1.51
Pattern of neuronal activity associated with conscious and unconscious processing of visual signals. Proc Natl Acad Sci U S A (1997) 1.51
Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry (1986) 1.51